COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, Stages, Life Extpectancy
Title: COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, Stages, Life ExtpectancyCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/6/2018 12:00:00 AM
Results of the first study to evaluate use of the adult COPD drug in children age 5 years and younger lay fertile ground for future trials.
Condition: Acute Exacerbation Copd Intervention: Diagnostic Test: procalcitonin Sponsor: University Hospital, Mahdia Recruiting
ConclusionsSmokers prescribed varenicline in primary care in the United Kingdom do not appear to be less likely to die, be hospitalized or experience a myocardial infarction or chronic obstructive pulmonary disease during the following 2 years compared with smokers prescribed nicotine replacement therapy, but they gain more weight and attend primary care less frequently.
This article summarizes the milestones in the development of benralizumab leading to this first approval for the treatment of severe eosinophilic asthma.
A vaccine against Moraxella catarrhalis would reduce tremendous morbidity, mortality, and financial burden by preventing otitis media in children and exacerbations of chronic obstructive pulmonary disease (COPD) in adults. Oligopeptide permease A (OppA) is a candidate vaccine antigen that is (i) a nutritional virulence factor expressed on the bacterial cell surface during infection, (ii) widely conserved among strains, (iii) highly immunogenic, and (iv) a protective antigen based on its capacity to induce protective responses in immunized animals. In the present study, we show that the antibodies to OppA following vaccinat...
COPD is a complex, heterogeneous disease characterised by progressive development of airflow limitation. Spirometry provides little information about key aspects of pathology and is poorly related to clinical ...
A socially assistive robot could be key to helping people with COPD manage their condition at home. A recent study published in JMIR, found that COPD patients that had a take-home a robot following a hospitalization were more likely to adhere to their medications and complete their rehabilitation excercises than their peers that did not have a robot.
Condition: COPD Exacerbation Intervention: Sponsor: Samsung Medical Center Enrolling by invitation
Conditions: Atelectasis; Pulmonary Infection; COPD; Pulmonary Disease; Hypoxemic Respiratory Failure; Hypoxemia; Morbid Obesity Interventions: Device: Bi-PAP; Device: Sham Bi-PAP Sponsors: Evangelismos Hospital; Elpis General Hospital; Sotiria General Hospital; Evgenidion Hospital Completed
Condition: COPD Interventions: Device: PrO2; Device: Threshold Inspiratory Muscle Trainer Sponsor: Miami VA Healthcare System Not yet recruiting